InvestorsHub Logo
Followers 5
Posts 107
Boards Moderated 0
Alias Born 06/18/2017

Re: poguemahone post# 135227

Sunday, 12/24/2017 2:04:12 PM

Sunday, December 24, 2017 2:04:12 PM

Post# of 458524
I'm operating under the assumption the reorganizing and shift in policies at the FDA, along with having to develop new approaches and then disseminate this information is the most likely reason for delay...we had a design plan prior but most likely it would have had to be refined once the FDA released its final design policies.most likely with Ariana involved they are trying to design the different trials so that each one builds on the other as far as information so the micro-management initially I believe it to be expected...Remember we saw unexpected results for the good in our P2a so loading the deck for a strong P3 is the right move. This company has the goods but because they don't have big money to back them if they make a mistake so they are dotting there i's and crossing their T's...Missling has kept his word every step of the way and he said they wouldn't move forward if they didn't have the goods...I'm giving him a free pass with the trials starting late as it's most likely on the FDA...but hopefully it is a learning experience for Missling with future decisions to talk with his shareholders about start dates...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News